Clinical Trial Update: AAV2-hAADC for Parkinson's Disease (PDCS-01) [Phase 1]

View source ↗

Summary

Phase 1 trial update on AAV2-hAADC for Parkinson's disease, including early-onset Parkinson's disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Early-onset Parkinson Disease
• Parkinson Disease

Drugs mentioned

• AAV2-hAADC (AAV2-hAADC)

Snippet

Sponsor: Krzysztof Bankiewicz | Conditions: Parkinson's Disease (PD), Early Onset Parkinson Disease | Phase 1 | Status: NOT_YET_RECRUITING